Financing - September 3, 2025
ProTest Diagnostics receives Wada grant
The company has secured a significant grant from the World Anti-Doping Agency (WADA) to develop technology aimed at detecting blood doping.
Biotech Business - August 29, 2025
Modus Therapeutics raises approximately SEK 28.3 million
The net proceeds of approximately SEK 24.4 million, of which approximately SEK 5 million refers to set-off against outstanding loans from Modus’ largest shareholder Karolinska Development, and after transaction costs of approximately SEK 3.9 million, will primarily be used to finance clinical activities, including the ongoing phase II study, states the company.
Pharma Business - August 27, 2025
Cereno Scientific granted FDA Fast Track Designation
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company's lead program, CS1, for the treatment of pulmonary arterial hypertension (PAH).
Biotech Business - August 25, 2025
Leqembi launched in the EU – Austria and Germany will mark the first launches
BioArctic's partner Eisai has announced that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025.
Collaboration - August 19, 2025
Novo Nordisk and BioMed X launch new collaboration
The partnership aims to address the challenge of efficient oral delivery of therapeutic peptides.
Intellectual Property - August 18, 2025
Faron announces extension to key patent family with new US patent granted
Faron Pharmaceuticals has announced that the United States Patent and Trademark Office has granted a new US Patent for treatment of Clever-1 positive cancers with bexmarilimab and related structures that would bind to Clever-1 molecule for the wanted re-programming effect.
